Target intelligence / Profile preview

Complement and contact system serine proteases

Molecular classification
Serine protease, Enzyme
01

Overview

The complement and contact system serine proteases are a functional group of enzymes that orchestrate the innate immune response and vascular regulation through highly regulated proteolytic cascades. The complement system utilizes proteases like C1r, C1s, and Factor D to mediate opsonization and cell lysis, while the contact system involves Factor XII and plasma kallikrein to generate bradykinin, a potent vasodilator [Source: UniProt, StatPearls]. Pathological overactivation or loss of endogenous regulation (e.g., C1-inhibitor deficiency) leads to life-threatening conditions such as hereditary angioedema (HAE) and atypical hemolytic uremic syndrome (aHUS) [Source: NIH]. Pharmacological intervention typically targets specific proteases to prevent the generation of pro-inflammatory peptides or the formation of the membrane attack complex. Modern therapeutics include monoclonal antibodies, small molecule inhibitors, and enzyme replacement therapies designed to restore balance to these complex systems [Source: PubMed PMID: 31558302].

Other names
Complement system proteasesContact system proteasesPlasma kallikrein-kinin system proteasesKKS proteases
02

Mechanism of action

Inhibition of specific serine proteases within the complement or contact cascades to prevent the formation of inflammatory mediators (like bradykinin or C5a) and the assembly of the membrane attack complex [Source: PubMed PMID: 32651006].

03

Biological functions

Immune responseInflammationCoagulationVasodilationProteolysisComplement activationVascular permeability regulation
04

Disease associations

Hereditary angioedemaParoxysmal nocturnal hemoglobinuriaAtypical hemolytic uremic syndromeSepsisThrombosisSystemic lupus erythematosusAge-related macular degeneration
05

Safety considerations

Increased susceptibility to encapsulated bacterial infections (e.g., Neisseria meningitidis)Risk of thrombosisHypersensitivity reactionsAutoantibody formationImpaired wound healing
06

Interacting drugs

C1-esterase inhibitor (Berinert, Cinryze, Haegarda)

7 more in the full profile.

07

Biomarkers

C1-inhibitor activityC4 levelsC3 levelsPlasma kallikrein activityCH50 (Total Hemolytic Complement)C5a levelsD-dimer

Beyond the preview

Go deeper on Complement and contact system serine proteases.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Complement and contact system serine proteases.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call